Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.76 USD | +0.48% | +3.30% | +18.83% |
Financials (USD)
Sales 2024 * | 4.49B | Sales 2025 * | 4.69B | Capitalization | 8.74B |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | 52M | EV / Sales 2024 * | 3.01 x |
Net Debt 2024 * | 4.77B | Net Debt 2025 * | 4.28B | EV / Sales 2025 * | 2.78 x |
P/E ratio 2024 * |
-421
x | P/E ratio 2025 * |
74.2
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on Elanco Animal Health Incorporated
1 day | +0.45% | ||
1 week | +5.30% | ||
1 month | +31.25% | ||
3 months | +10.29% | ||
6 months | +42.58% | ||
Current year | +18.66% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Simmons
CEO | Chief Executive Officer | 56 | 18-06-30 |
Todd Young
DFI | Director of Finance/CFO | 52 | 18-12-13 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 20-12-13 |
Art Garcia
BRD | Director/Board Member | 63 | 19-05-07 |
John Bilbrey
BRD | Director/Board Member | 67 | 19-03-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.88% | 254 M€ | +13.69% | - | |
10.49% | 1 M€ | -.--% | ||
0.35% | 17 M€ | +7.32% | - | |
0.33% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 17.72 | +0.20% | 1 009 484 |
24-05-31 | 17.68 | +0.45% | 6,101,493 |
24-05-30 | 17.6 | +1.15% | 4,998,063 |
24-05-29 | 17.4 | +1.52% | 6,041,537 |
24-05-28 | 17.14 | +2.08% | 5,372,094 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.66% | 8.74B | |
-14.09% | 77.37B | |
+23.75% | 3.67B | |
-1.25% | 3.25B | |
+17.74% | 1.73B | |
-16.99% | 1.38B | |
-0.20% | 1.31B | |
-26.05% | 1.24B | |
-17.86% | 1.07B | |
-6.77% | 976M |
- Stock Market
- Equities
- ELAN Stock